T2	Disorder 30 48	phenytoin toxicity
T3	Pharmacological_substance 56 65	erlotinib
N1000 	Reference T3 MeSH:D000069347	erlotinib
T4	Disorder 124 159	advanced non-small cell lung cancer
T5	Pharmacological_substance 194 207	antiepileptic
N1001 	Reference T5 MeSH:D000927	antiepileptic
T9	Pharmacological_substance 316 331	Anticonvulsants
N1002 	Reference T9 MeSH:D000927	Anticonvulsants
T10	Disorder 398 409	brain tumor
N1 	Reference T10 UMLS:C0006118	brain tumor
T11	Pharmacological_substance 496 505	phenytoin
N1003 	Reference T11 MeSH:D010672	phenytoin
T12	Pharmacological_substance 533 542	erlotinib
N1004 	Reference T12 MeSH:D000069347	erlotinib
T13	Pharmacological_substance 582 591	phenytoin
N1005 	Reference T13 MeSH:D010672	phenytoin
T15	Subject 110 118	patients
T16	Disorder 67 83	Brain metastases
N2 	Reference T16 UMLS:C0220650	Brain metastases
T17	Pharmacological_substance 212 234	chemotherapeutic drugs
N1006 	Reference T17 MeSH:D000970	chemotherapeutic drugs
T7	Pharmacological_substance 238 287	epidermal growth factor receptor (EGFR) inhibitor
T8	Combination 164 175	concomitant
T19	Subject 410 418	patients
T22	Disorder 487 512	elevated phenytoin levels
N3 	Reference T22 UMLS:C0587372	elevated phenytoin levels
T24	Speculation_cue 448 457	potential
T18	Pharmacological_substance 30 39	phenytoin
N1007 	Reference T18 MeSH:D010672	phenytoin
